Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have different hormone levels, and these hormones can affect hair growth.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia have lower SHBG levels.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finasteride safely reduces excessive hair growth in women.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Taking biotin can lead to incorrect low results in free testosterone tests.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.